Categories
Latest Industry Intelligence
Currently, no effective cure or treatment for Huntington’s disease exists. To accelerate Huntington’s disease research [...]
With European life sciences R&D investment at a 20-year low, biopharmaceutical associations and MEPs are [...]
DDW Editor, Reece Armstrong, sits down with Brinter CEO Tomi Kalpio to learn about the company’s approach to bioprinting and how it can be used throughout drug discovery. Brinter is a provider of 3D bioprinting solutions based in Turku, Finland and the US. The company has developed modular technology that can print multi-material and highly […]
Menu ≡ ╳ 
